These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14792459)

  • 1. Some effects of intravenous injections of saccharated iron oxide on serum iron and unsaturated iron binding capacity.
    CAMERON DG; BENSLEY EH; WOOD P
    Can Med Assoc J; 1951 Jan; 64(1):30-1. PubMed ID: 14792459
    [No Abstract]   [Full Text] [Related]  

  • 2. The immediate hematologic effects of intravenous saccharated iron oxide.
    WHITE LP; BIERMAN HR; KELLY KH; BYRON RL
    Blood; 1952 Sep; 7(9):897-903. PubMed ID: 14953947
    [No Abstract]   [Full Text] [Related]  

  • 3. The hematologic response of the pregnant woman to intravenous saccharated iron oxide.
    NICHOLSON DB; ASSALI NS
    Surg Gynecol Obstet; 1952 May; 94(5):513-8. PubMed ID: 14922134
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations.
    NISSIM JA
    Br Med J; 1954 Feb; 1(4858):352-6. PubMed ID: 13115719
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous iron therapy with saccharated iron oxide.
    DESHMUKH PL
    Ind Med Gaz; 1952 Jul; 87(7):287-92. PubMed ID: 12990194
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route.
    CAMERON DG; BENSLEY EH; WOOD P; GRAYSTON V
    Can Med Assoc J; 1951 Jan; 64(1):27-30. PubMed ID: 14792458
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology.
    HOLLY RG
    Blood; 1951 Nov; 6(11):1159-72. PubMed ID: 14869375
    [No Abstract]   [Full Text] [Related]  

  • 8. Histological appearances following intravenous saccharated iron oxide, and the factors governing precipitation of the compound in vivo.
    NISSIM JA
    Guys Hosp Rep; 1953; 102(2):164-79. PubMed ID: 13044079
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide].
    Konjiki O; Fukaya S; Kanou H; Imamura T; Iwamoto T; Takasaki M
    Nihon Ronen Igakkai Zasshi; 1994 Oct; 31(10):805-10. PubMed ID: 7853746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental investigations on saccharated iron oxide.
    HAGBERG B; VAHLQUIST B; DICKIE W
    Acta Soc Med Ups; 1953; 58(1-2):73-82. PubMed ID: 13057653
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ferropenic anemia: some comments].
    Juncà J
    Med Clin (Barc); 2006 Nov; 127(20):796. PubMed ID: 17198668
    [No Abstract]   [Full Text] [Related]  

  • 12. Staining of fungi with saccharated iron oxide.
    CIBIS PA; YAMASHITA T
    Stain Technol; 1959 May; 34(3):129-33. PubMed ID: 13659241
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancing effect of saccharated ferric oxide on human lymphocyte transformation in serum-free medium.
    Tanno Y; Takishima T
    Tohoku J Exp Med; 1982 Apr; 136(4):463-4. PubMed ID: 7101280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Information on injectable saccharated ferric oxide].
    BUCHI J; ZOPPI-HUG R
    Pharm Acta Helv; 1956 Nov; 31(11):497-517. PubMed ID: 13388605
    [No Abstract]   [Full Text] [Related]  

  • 15. Staining of the retina with saccharated iron oxide.
    YAMASHITA T; CIBIS PA
    AMA Arch Ophthalmol; 1959 May; 61(5):698-708. PubMed ID: 13636564
    [No Abstract]   [Full Text] [Related]  

  • 16. [Knowledge on injectible saccharated ferric oxide].
    BUCHI J; ZOPPI-HUG R
    Dan Tidsskr Farm; 1956 Sep; 30(Suppl 2):41-64. PubMed ID: 13375120
    [No Abstract]   [Full Text] [Related]  

  • 17. The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures.
    Sunder-Plassmann G; Spitzauer S; Hörl WH
    Nephrol Dial Transplant; 1997 Aug; 12(8):1575-80. PubMed ID: 9269632
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypophosphatemia induced by intravenous administration of Saccharated iron oxide.
    Okada M; Imamura K; Iida M; Fuchigami T; Omae T
    Klin Wochenschr; 1983 Jan; 61(2):99-102. PubMed ID: 6843038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and standardization of saccharated iron oxide for intra venous administration.
    NISSIM JA; ROBSON JM
    Lancet; 1949 Apr; 1(6556):686-9. PubMed ID: 18118003
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous treatment of anaemia with an iron-sucrose preparation.
    SLACK HG; WILKINSON JF
    Lancet; 1949 Jan; 1(6540):11-4. PubMed ID: 18208026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.